Ways Out of the Patenting Prohibition? Human Parthenogenetic and Induced Pluripotent Stem Cells

Bioethics 31 (5):409-417 (2017)
  Copy   BIBTEX

Abstract

According to the judgement of the European Court of Justice in 2014, human parthenogenetic stem cells are excluded from the patenting prohibition of procedures based on hESC by the European Biopatent Directive, because human parthenotes are not human embryos. This article is based on the thesis that in light of the technological advances in the field of stem cell research, the attribution of the term ‘human embryo’ to certain entities on a descriptive level as well as the attribution of a normative protection status to certain entities based on the criterion of totipotency, are becoming increasingly unclear. The example of human parthenotes in particular demonstrates that totipotency is not at all a necessary condition for the attribution of the term ‘human embryo’. Furthermore, the example of hiPSC and somatic cells particularly shows that totipotency is also not a sufficient condition for the attribution of a normative protection status to certain entities. Therefore, it is not a suitable criterion for distinguishing between human embryos worthy of protection and human non-embryos not worthy of protection. Consequently, this conclusion has repercussions for the patenting question. The strict delineation between an ethically problematic commercial use of human embryos and the concomitant patenting prohibition of hESC-based procedures and an ethically unproblematic commercial use of human non-embryos and the therefore either unrestrictedly permitted or even unregulated patenting of procedures based on these alleged alternatives becomes increasingly blurred.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,069

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Embryonic Stem Cell Patents and Human Dignity.David B. Resnik - 2007 - Health Care Analysis 15 (3):211-222.
Some Ethical Concerns About Human Induced Pluripotent Stem Cells.Yue Liang Zheng - 2016 - Science and Engineering Ethics 22 (5):1277-1284.
Human embryonic stem cell research and the discarded embryo argument.Mark Moller - 2009 - Theoretical Medicine and Bioethics 30 (2):131-145.
On the German debate on human embryonic stem cell research.Jan P. Beckmann - 2004 - Journal of Medicine and Philosophy 29 (5):603 – 621.
Embryonic Stem Cells and Property Rights.A. -K. M. Andersson - 2011 - Journal of Medicine and Philosophy 36 (3):221-242.

Analytics

Added to PP
2017-02-09

Downloads
16 (#789,512)

6 months
4 (#368,572)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Citations of this work

Decyzje w sytuacjach niepewności normatywnej.Tomasz Żuradzki - 2020 - Przeglad Filozoficzny - Nowa Seria 29 (2):53-72.

Add more citations

References found in this work

We have never been modern.Bruno Latour - 1993 - Cambridge, Mass.: Harvard University Press.
Stammzellforschung in Deutschland – Möglichkeiten und Perspektiven.[author unknown] - 2007 - Jahrbuch für Wissenschaft Und Ethik 12 (1):463-468.

Add more references